Regeneron Pharmaceuticals
REGN
#319
Rank
NZ$136.92 B
Marketcap
NZ$1,330
Share price
0.80%
Change (1 day)
35.69%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2026 (TTM): NZ$8.98 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are NZ$15.53 Billion. In 2025 the company made an earning of NZ$9.33 Billion, an increase over its 2024 earnings that were of NZ$8.52 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 1990 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$8.98 B-3.77%
2025 NZ$9.33 B9.43%
2024 NZ$8.52 B13.83%
2023 NZ$7.49 B-13.57%
2022 NZ$8.66 B-47.9%
2021 NZ$16.63 B144.75%
2020 NZ$6.79 B56.86%
2019 NZ$4.33 B-4.87%
2018 NZ$4.55 B22.86%
2017 NZ$3.70 B56.3%
2016 NZ$2.37 B8.55%
2015 NZ$2.18 B54.53%
2014 NZ$1.41 B11.14%
2013 NZ$1.27 B72.13%
2012 NZ$0.73 B-285.93%
2011 -NZ$0.4 Billion121.73%
2010 -NZ$0.18 Billion37.18%
2009 -NZ$0.14 Billion-14.6%
2008 -NZ$0.16 Billion-25.02%
2007 -NZ$0.21 Billion6.32%
2006 -NZ$0.2 Billion-186.52%
2005 NZ$0.22 B2103.7%
2004 NZ$10.07 M-105.66%
2003 -NZ$0.18 Billion-18.18%
2002 -NZ$0.22 Billion42.33%
2001 -NZ$0.16 Billion129.35%
2000 -NZ$66.66 Million51.87%
1999 -NZ$43.89 Million92.19%
1998 -NZ$22.84 Million66.23%
1997 -NZ$13.74 Million-55.49%
1996 -NZ$30.87 Million103.53%
1995 -NZ$15.17 Million-70.89%
1994 -NZ$52.1 Million-26.08%
1993 -NZ$70.48 Million114.67%
1992 -NZ$32.83 Million196.77%
1991 -NZ$11.07 Million87.88%
1990 -NZ$5.89 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$46.75 B 407.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$27.69 B 200.46%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
NZ$18.35 B 99.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$12.77 B 38.60%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$1.80 B-80.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$2.00 B-78.23%๐Ÿ‡บ๐Ÿ‡ธ USA